2023 ASCRS Subspecialty Day CME Credit
The American Society of Cataract and Refractive Surgery is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. ASCRS takes responsibility for the content, quality and scientific integrity of the CME activity.
The American Society of Cataract and Refractive Surgery designates the ASCRS Subspecialty Day Programs for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
All CME activities approved for AMA PRA Category 1 Credit™ are valid for recognition by the European Accreditation Council for Continuing Medical Education (EACCME). Physicians not licensed in the U.S. who participate in this CME activity are eligible for AMA PRA Category 1 Credit™.
Physicians can claim CME credit up to the maximum listed above for attending the Physicians Program (ASCRS), including scientific films and posters on-demand, scientific papers, courses, symposia and general sessions). Attendees registered as exhibitors, spouses, and guests are not eligible for CME credits. Note: All attendees must have their badges visit a badge verification station to be eligible to claim credits and evaluate the program.
ASCRS Cornea Day
Practicing ophthalmologists who care for patients with corneal‐related conditions
- Describe updates in surgical cornea- management of Fuchs Dystrophy, posterior lamellar keratoplasty updates, keratoprosthesis and emerging technologies
- Discover treatment options for management of corneal infections and chronic corneal inflammatory disorders
- Employ strategies for managing complex cornea cases in treating complex IOL cases, open sky, complex EK and artificial irises
- Discuss office-based corneal disease management; to include the management of keratoconus, corneal collagen crosslinking, herpes eye disease, and infectious keratitis
- Examine current research related to the etiology and treatment of ocular surface diseases
- Develop strategies to identify and efficiently manage patients with severe ocular surface disease, dry eye disease and surface neoplasias